Bibliography
- Ständer S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the international forum for the study of itch. Acta Derm Venereol 2007;87:291-4
- Valdes-Rodriguez R, Stull C, Yosipovitch G. Chronic pruritus in the elderly: pathophysiology, diagnosis and management. Drugs Aging 2015;32:201-15
- Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries. J Invest Dermatol 2015;135:984-91
- Weisshaar E, Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol 2009;89:339-50
- Weiss M, Mettang T, Tschulena U, et al. Prevalence of chronic itch and associated factors in haemodialysis patients: A Representative Cross-sectional Study. Acta Derm Venereol 2015. [Epub ahead of print]
- Kremer AE, Bolier R, van Dijk R, et al. Advances in pathogenesis and management of pruritus in cholestasis. Dig Dis 2014;32:637-45
- Matterne U, Apfelbacher CJ, Loerbroks A, et al. Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol 2011;91(6):674-9
- Matterne U, Apfelbacher CJ, Vogelgsang L, et al. Incidence and determinants of chronic pruritus: a population-based cohort study. Acta Derm Venereol 2013;93(5):532-7
- Weisshaar E, Szepietowski JC, Darsow U, et al. European Guideline on chronic pruritus. Acta Derm Venereol 2012;92:563-81
- Ständer S, Darsow U, Mettang T, et al. [S2k guideline--chronic pruritus]. J Dtsch Dermatol Ges 2012;10(Suppl 4):S1-27
- Ständer S, Pogatzki-Zahn E, Stumpf A, et al. Facing the challenges of chronic pruritus: a report from a multi-disciplinary medical itch centre in Germany. Acta Derm Venereol 2015;95(3):266-71
- Ständer S, Zeidler C, Magnolo N, et al. Clinical management of pruritus. J Dtsch Dermatol Ges 2015;13:101-14
- Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004;5(7):752-60
- Raap U, Wichmann K, Bruder M, et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 2008;122:421-3
- Cevikbas F, Wang X, Akiyama T, et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. J Allergy Clin Immunol 2014;133(2):448-60
- Toyoda M, Nakamura M, Makino T, et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002;147(1):71-9
- Ständer S, Siepmann D, Herrgott I, et al. Targeting the neurokinin receptor 1 with aprepitant: A Novel Antipruritic Strategy. PLoS One 2010;5(6):e10968
- Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002683/WC500158832.pdf
- Kuiper EM, van Erpecum KJ, Beuers U, et al. The bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial. Hepatology 2010;52:1334-40
- Wallengren J, Edvinsson L. Topical non-peptide antagonists of sensory neurotransmitters substance P and CGRP do not modify patch test and prick test reactions: a vehicle-controlled, double-blind pilot study. Arch Dermatol Res 2014;306:505-9
- Available from: http://www.newswise.com/articles/velocity-pharmaceutical-development-llc-and-tigercat-pharma-inc-announce-phase-2-results-for-vpd-737-in-patients-with-chronic-pruritus
- Bautista DM, Wilson SR, Hoon MA. Why we scratch an itch: the molecules, cells and circuits of itch. Nat Neurosci 2014;17:175-82